Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-21

FDA Approved: GIAPREZA — Original Application (La Jolla Pharmaceutical Company)

View source ↗

Summary

GIAPREZA (angiotensin II) was approved to increase blood pressure in adults with septic or other distributive shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Giapreza (Angiotensin II)

Snippet

ORIG AP for GIAPREZA (ANGIOTENSIN II)